ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1426	National Cancer Institute	Html	en	Childhood Ependymoma Treatment (PDQ®)–Health Professional Version	In childhood ependymoma, cancer forms in the tissues of the brain and spinal cord. The cause of ependymoma is unknown. Find out about the molecular and clinical features, diagnosis, prognosis, treatment, and clinical trials for pediatric ependymoma, subependymoma, myxopapillary ependymoma, anaplastic ependymoma, and RELA fusion–positive ependymoma.	childhood recurrent ependymoma 0.446141 Merchant TE 0.374501 Brain Tumor Registry 0.351132 childhood brain tumor 0.35242 spinal cord ependymomas 0.479172 nervous system ependymoma 0.395153 posterior fossa ependymoma 0.628195 brain tumors 0.516421 children 0.409198 malignant brain tumors 0.384396 newly diagnosed ependymoma 0.411931 Sayegh ET 0.377382 Int J Radiat 0.476989 Radiat Oncol Biol 0.6983 World Health Organization 0.41477 intracranial ependymoma recurrence 0.508211 pediatric supratentorial tumors 0.369961 posterior fossa tumors 0.3562 infratentorial ependymoma 0.423041 ependymoma patients 0.42421 intracranial ependymomas 0.39986 Supratentorial ependymoma 0.435338 Clin Cancer Res 0.386576 paediatric ependymoma 0.450128 pediatric intracranial ependymoma 0.570833	radiation therapy 0.449829 Acta Neuropathol 0.35243 et al. 0.743726 childhood ependymoma 0.513088 intracranial ependymoma 0.927373 recurrent ependymoma 0.45402 Neuro Oncol 0.356088 primary brain tumors 0.39985 pediatric intracranial ependymomas 0.371298 adult ependymoma cases 0.44321 Pediatr Blood Cancer 0.534048 childhood ependymomas 0.358916 Metastatic ependymoma 0.401089 posterior fossa ependymomas 0.381573 spinal cord 0.504643 Abstract 0.696 non-anaplastic ependymoma 0.396839 childhood intracranial ependymoma 0.687299 Clin Oncol 0.484182 childhood brain tumors 0.3515 Oncol Biol Phys 0.714533 spinal canal ependymoma 0.421296 Central Brain Tumor 0.351707 Childs Nerv Syst 0.489135	CLICK HERE
1558	National Cancer Institute	Html	en	Endometrial Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing endometrial cancer and about research aimed at the prevention of this disease.	cancer treatment 0.459672 cancer prevention trials 0.519855 estrogen 0.503683 endometrial cancer prevention 0.633127 protective factors 0.494311 following PDQ summaries 0.487054 PDQ cancer information 0.583616 estrogen receptor modulators 0.479388 oral contraceptives increases 0.455046 uterus 0.455824 clinical trials 0.591442 cancer information summary 0.536389 breast cancer prevention 0.515055 cancer patients 0.456862 cancer risk factor 0.514935 NCI’s PDQ 0.460213 metabolic syndrome 0.469608 Clinical Trials section 0.455747 NCI PDQ cancer 0.511939 endometrial hyperplasia 0.525569 hormone replacement therapy 0.4814 new cases 0.45495 estrogen levels 0.496361 cancer risk factors 0.513284	Cancer prevention 0.648371 cancer protective factor 0.491722 high estrogen levels 0.479463 Cancer Information Service 0.48404 polycystic ovary syndrome 0.484739 prevention clinical trials 0.493334 Prevention Editorial Board 0.485326 treatment clinical trials 0.456257 National Cancer Institute 0.542099 endometrial cancer 0.951484 African American women 0.525683 estrogen therapy 0.459908 higher risk 0.454955 postmenopausal women 0.557323 Cancer Care page 0.476271 PDQ database 0.456704 PDQ summary 0.495085 combination oral contraceptives 0.477913 cancer clinical trials 0.489805 risk factors 0.587492 nonpolyposis colon cancer 0.481746 cancer information summaries 0.48866 comprehensive cancer information 0.488387 risk 0.63452	CLICK HERE
1825	National Cancer Institute	Html	es	Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento cáncer de hígado infantil.	liver tumors 0.936797 Pediatric Oncology 0.824708 PRETEXT III 0.10879 Aronson DC 0.0851201 results from 0.266716 Paediatric Oncology 0.0823629 international pediatric liver 0.110029 Tumor Study Group 0.204309 standard-risk hepatoblastoma 0.125193 childhood liver tumors 0.0905382 Study Group 0.298822 Maibach R 0.0922692 hepatocellular carcinoma 0.861587 International Society 0.42048 IV hepatoblastoma 0.218263 Krailo MD 0.0915991 cog liver tumors 0.124853 Children's Oncology Group 0.248758 Estados Unidos 0.091099 hepatoblastoma with 0.740659 pediatric liver tumors 0.222622 hepatoblastoma after chemotherapy 0.124744 Pediatric Oncology Liver 0.123326 childhood hepatoblastoma 0.552956 with hepatoblastoma 0.638805	Perilongo G 0.171974 PRETEXT IV 0.0802866 grupos pretext 0.174753 Group intergroup study 0.0861929 Pediatr Blood Cancer 0.319797 Oncology Group study 0.119848 childhood liver 0.102417 Japanese Study Group 0.0968813 report from 0.211803 Childrens Cancer Study 0.0958008 quimioterapia preoperatoria 0.196007 Hepatoblastoma presenting with 0.134427 Liver Tumor Study 0.217304 Pediatr Surg 0.270609 Clin Oncol 0.979661 Hepatoblastoma metastatic 0.11507 Otte JB 0.0939222 Children's Cancer Group 0.202883 Shafford E 0.259892 prospective study 0.154606 Oncology Liver Tumor 0.132492 pediatric oncology group 0.588258 oncology group 0.803949 Cancer Study Group 0.108904	CLICK HERE
1879	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama) en el embarazo.	Chua T 0.308433 Rugo HS 0.308741 exposed to chemotherapy 0.30311 Surg Gynecol Obstet 0.330452 outcome after 0.304299 pregnant patient 0.315879 anomalías congénitas 0.308598 Clark RM 0.307911 Theriault R 0.32478 cancer diagnosed during 0.342035 diagnosed during pregnancy 0.34332 Loprinzi CL 0.304379 Sin embargo 0.313532 patient with carcinoma 0.318411 mother during gestation 0.303218 Instituto Nacional 0.305213 Petrek JA 0.304025 Yang WT 0.304051 breast carcinoma during 0.308603 breast carcinoma 0.313568 Gynecol Oncol 0.302701 altas concentraciones 0.304242 cancer diagnosed 0.35036 safety after breast 0.308046 chemotherapy during pregnancy 0.3192	Curr Treat Options 0.317342 administration during pregnancy 0.307821 overall survival after 0.302827 R Coll Radiol 0.316078 Wallack MK 0.309132 Gallenberg MM 0.304139 ultimate challenge 0.308285 Surg Clin North 0.303453 National Cancer Institute 0.306047 during pregnancy 0.532041 Surg Oncol 0.303192 pregnant patient with 0.318156 PDQ Tratamiento 0.303689 after maternal cancer 0.306691 Clin Oncol 0.325015 Radiotherapy during pregnancy 0.307723 breast cancer 0.976679 systematic review 0.303372 Treat Options Oncol 0.318121 Dryden MJ 0.304024 breast cancers from 0.308506 with or without 0.302892 as systemic treatment 0.302539 Gwyn K 0.36898	CLICK HERE
1911	National Cancer Institute	Html	es	Tratamiento del cáncer de células renales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de células renales.	siguientes procedimientos 0.302667 mal uso 0.302989 siguientes aspectos 0.301319 estadio ii 0.309628 túbulos renales 0.304796 pequeños trozos 0.300679 siguientes tipos 0.302146 Renal Cell 0.303601 rayos x 0.302568 sistema urinario masculino 0.3018 enlace drugs approved 0.306606 riñón sano donado 0.303031 National Cancer Institute 0.300453 siguientes riesgos 0.300391 realidad células 0.303887	pelvis renal 0.306725 Instituto Nacional 0.301826 PDQ Tratamiento 0.304405 Physician Data Query 0.301827 nefrectomía radical 0.310748 pequeña incisión 0.300747 tumor mide 0.303146 von hippel-lindau 0.30106 vejiga almacena 0.301249 pequeños túbulos 0.301281 siguientes enlaces 0.300545 células renales 0.988263 riesgo cáncer 0.31289 siguientes pruebas 0.301322 vasos sanguíneos 0.317262	CLICK HERE
1977	National Cancer Institute	Html	es	Tratamiento del carcinoma de corteza suprarrenal (PDQ®)–Versión para pacientes	Resumen de revisión revisada por expertos acerca del tratamiento del carcinoma de corteza suprarrenal.	siguientes procedimientos 0.496457 tinte circula 0.500083 pequeña cantidad 0.426407 estadio ii 0.722852 vía oral 0.42258 rayos x 0.485722 ondas sonoras 0.428325 National Cancer Institute 0.418399 sustancia llamada gadolinio 0.451231 suprarrenal elabora hormonas 0.951617 siguientes riesgos 0.416128 secciones cáncer 0.564083 Instituto Nacional 0.51582 PDQ Tratamiento 0.443801 siguientes hormonas 0.456613	presente sección 0.419609 corteza suprarrenal causa 0.829807 siguientes funciones 0.454626 Physician Data Query 0.471125 médula suprarrenal.Ampliar 0.44071 estadio iii 0.71977 características masculinas 0.438548 siguientes enfermedades 0.449744 PDQ Feocromocitoma 0.493816 suprarrenal causa efectos 0.739636 siguientes terapias 0.423482 PDQ Cánceres 0.484481 siguientes enlaces 0.420507 suprarrenal funcionante elabora 0.710246 siguientes pruebas 0.503631	CLICK HERE
2071	National Cancer Institute	Html	es	Cirugía para reducir el riesgo de cáncer de seno	Hoja informativa que describe las clases de cirugía para reducir el riesgo de cáncer de seno y las situaciones en las que se puede pensar en esas operaciones.	Surgical Adjuvant Breast 0.526694 PROSE Study Group 0.516256 cáncer invasor 0.567762 brca1 or brca2 0.538495 mastectomía subcutánea 0.530865 Preventing breast 0.511838 Breast Cancer Research 0.523551 risk-reducing surgery 0.507962 with brca1 or 0.509298 brca2 mutation 0.564149 breast screening with 0.51472 Preventive Services Task 0.512338 mastectomy reduces breast 0.516804 alta penetrancia 0.508455 risk after smaller 0.509063 Friebel T 0.508008 PubMed Abstract 0.952028 Clinical Oncology 0.653359 Cancer Journal 0.515034 BRCA2 mutation carriers 0.554396 early breast cancer 0.539203 ¿Cuáles mujeres 0.517292 bilateral mastectomy 0.517477 BRCA2 mutations detected 0.508495 alto riesgo 0.656597	Wickerham DL 0.51571 an overview 0.508367 Costantino JP 0.515178 Cancer Risk Assessment 0.519342 Rebbeck TR 0.508232 developing invasive breast 0.513495 antecedentes familiares 0.554456 riesgo promedio 0.539499 or brca2 mutations 0.536318 breast cancer risk 0.617067 mutation carriers with 0.509322 gen pten 0.510383 breast cancer 0.801718 Breast Cancer Trialists 0.522907 Services Task Force 0.511925 prophylactic mastectomy 0.591377 mujeres portadoras 0.533011 gen brca1 0.561202 contralateral prophylactic mastectomy 0.534028 Cancer Institute 0.511805 Clinical Cancer Research 0.516971 gen brca2 0.561192 gen tp53 0.518098 New England Journal 0.535054	CLICK HERE
2988	National Cancer Institute	Html	en	Secondhand Smoke	Smoking affects both you and your loved one's health. Learn about the consequences of secondhand smoke and how you can protect your family.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
4337	National Cancer Institute	Html	en	Appetite Loss and Cancer Treatment	Cancer treatments may lower your appetite. Side effects such as nausea, fatigue, or mouth sores can also making eating difficult. Learn how to eat well to avoid losing weight or becoming dehydrated, so you stay strong during treatment.	Care PDQ® summary 0.905921 questions 0.493671 liquids 0.644562 dietitian 0.466542 short walk 0.691875 health care team 0.956003 professional version 0.683094 variety 0.451735 causes 0.450224 nurse 0.455725 Prepare 0.451462 dehydration 0.472596 throat problems 0.73358 drink choices 0.682925 vomiting 0.475861 food tastes 0.745638 Cancer treatments 0.729931 cancer patients 0.671489 supplemental nutrition drinks 0.886258 weight 0.457616 large meals 0.701392 plenty 0.541422	calories 0.468062 list 0.493655 eating 0.456684 steps 0.457353 people 0.451814 dangerous condition 0.706738 small meals 0.702125 way 0.460708 nausea 0.479468 nutritional problems 0.667746 doctor 0.457447 symptoms 0.451468 supplements 0.451833 Cancer-related fatigue 0.794241 effects 0.460377 mouth 0.464482 vitamins 0.459091 NCI 0.456663 high-nutrient foods 0.702331 appetite 0.964964 information 0.45027 nutrient-dense foods 0.715035	CLICK HERE
16645	National Cancer Institute	Html	en	Understanding “Chemobrain” and Cognitive Impairment after Cancer Treatment	An NCI research update about research to investigate what factors play a role in “chemobrain” or cognitive impairment after cancer treatment.	cognitive problems 0.439925 cognitive behavioral therapy 0.339182 cancer treatment 0.685512 cognitive effects 0.256058 self-reported cognitive functioning 0.391696 lower cognitive performance 0.348528 cognitive decline 0.284161 chemotherapy 0.377855 long-term cognitive changes 0.331518 chemotherapy treatment 0.254041 cognitive challenges 0.286627 cognitive issues 0.282189 Kettering Cancer Center 0.246129 chemotherapy-associated cognitive impairment 0.369163 Wilmot Cancer Institute 0.218061 Dr. Ganz 0.536508 Jonsson Comprehensive Cancer 0.230946	Dr. Ahles 0.527642 cognitive rehabilitation program 0.323502 cognitive changes 0.469428 healthy women 0.234218 breast cancer patients 0.251612 recent research 0.354647 patients 0.34223 Cancer Therapy-Cognitive Function 0.218486 breast cancer survivors 0.783509 cognitive difficulties 0.366868 treatment-related cognitive impairment 0.464189 hormonal therapy 0.233078 self-reported cognitive complaints 0.381226 cognitive symptoms 0.25427 cognitive impairment 0.941275 neuropsychological tests 0.263188	CLICK HERE